Incarceration linked to excess burden of cancer, new study finds

February 22, 2017

TORONTO, Feb. 22, 2017 -- People who spend time in jails and prisons are more likely to develop certain types of cancer than the general population in Ontario, according to a study published today in the open-access journal PLOS ONE.

They were also more than 50 per cent more likely to die from cancer than the general population in Ontario, the study found. Men were more than three times as likely as men in the general population to die from head and neck and liver cancer and women were three times as likely as women in the general population to die from cervical cancer.

Dr. Fiona Kouyoumdjian, a researcher at St. Michael's Hospital and McMaster University and lead author of the study, said the findings could be the result of high rates of risk factors for cancer in this population.

"We know that people who spend time in jails and prisons in Canada are more likely to use alcohol and tobacco, as well as have infections such as HPV (human papillomavirus) and HIV, which can increase the risk of developing some types of cancer," she said.

The researchers followed almost 50,000 people who were admitted to provincial jails in Ontario in 2000 to study how many people developed cancer and how many people died from cancer over a 12-year period.

Between 2000 and 2012, 2.6 per cent of men and 2.8 per cent of women who spent time in jail or prison were diagnosed with new cancers. The most common types of cancer for men were lung, prostate, colorectal and head and neck, while the most common types of cancer for women were breast, lung and cervical.

Over the followup period, 1.1 per cent of men and 0.9 per cent of women who spent time in jail or prison died from cancer. Adjusted for age, the mortality rate was 1.6 times higher for men and 1.4 times higher for women in this population compared to the general population in Ontario. The mortality rate was higher in men for any cancer, lung cancer, liver cancer, and head and neck cancer, and in women for lung, liver and head and neck cancers compared to the general population.

Dr. Kouyoumdjian said the study showed that cancer prevention efforts should include people who have spent time in jails or prisons.

"Incarceration represents a chance to help people improve their health through the provision of services and linkage with programs in the community," she said.

"Specific strategies that could prevent cancer in this population include smoking cessation, vaccination for HPV and HBV, pap screening and treatment for hepatitis C, and these strategies could have a large impact given that many people who experience incarceration are quite young."
-end-
About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contacts

For media inquiries, please contact:

Kelly O'Brien
Communications Adviser - Media, St. Michael's Hospital
416-864-5047
obrienkel@smh.ca

St. Michael's Hospital

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.